TAV-in-TAV for failed prosthesis: the new frontier
June 12, 2020 | 10.4244/EIJV16I2A15
Showing 1-20 of 22 articles
Interventions for valvular disease
Transcatheter mitral valve replacement: factors associated with screening success and failure December 6, 2019 | 10.4244/EIJ-D-19-00444
Improving our knowledge about a new plug-based vascular closure device
May 20, 2019 | 10.4244/EIJV15I1A4
TAVI and the brain: update on definitions, evidence of neuroprotection and adjunctive pharmacotherapy
September 7, 2018 | 10.4244/EIJ-D-18-00454
Interventions for valvular disease
Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve August 3, 2018 | 10.4244/EIJ-D-17-01040
Interventions for valvular disease
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients September 20, 2017 | 10.4244/EIJ-D-16-01024
Interventions for valvular disease
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort September 20, 2017 | 10.4244/EIJ-D-16-01025
Interventions for valvular disease
The SURTAVI study: TAVI for patients with intermediate risk August 4, 2017 | 10.4244/EIJV13I5A97
Interventions for valvular disease
How should I treat a patient with a symptomatic and severe low-flow low-gradient aortic stenosis and an incidental abdominal aortic aneurysm? July 20, 2017 | 10.4244/EIJ-D-16-00461
Interventions for valvular disease
Annulus rupture post transcatheter aortic valve implantation complicated by a giant pseudoaneurysm February 3, 2017 | 10.4244/EIJ-D-16-00347
Interventions for valvular disease
A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis December 9, 2016 | 10.4244/EIJ-D-15-00511
Interventions for valvular disease
Impact of permanent pacemaker on mortality after transcatheter aortic valve implantation: the PRAGMATIC (Pooled Rotterdam-Milan-Toulouse in Collaboration) Pacemaker substudy October 20, 2016 | 10.4244/EIJV12I9A192
Interventions for valvular disease
Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 1: systematic measurement methodology and inter-observer variability October 10, 2016 | 10.4244/EIJY15M11_09
Interventions for valvular disease
In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart valves September 18, 2016 | 10.4244/EIJV12I7A149
Interventions for valvular disease
TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery September 18, 2016 | 10.4244/EIJV12SYA6
Interventions for valvular disease
Current decision making and short-term outcome in patients with degenerative aortic stenosis: the Pooled-RotterdAm-Milano-Toulouse In Collaboration Aortic Stenosis survey February 12, 2016 | 10.4244/EIJV11I10A253
Interventions for valvular disease
Edwards SAPIEN 3 implanted in a failing aortic bioprosthesis: first report February 12, 2016 | 10.4244/EIJV11I11A255
New-generation TAVI devices: description and specifications
September 27, 2014 | 10.4244/EIJV10SUA13
Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system
September 28, 2012 | 10.4244/EIJV8I5A86